This exploration was carried out To judge the possible of the CPPs with tumor-focusing on Attributes to deliver a cytotoxic payload to HCC cells. We explored using a CXCR4-targeting peptide, T22, fused with cytotoxic peptide PE24, like a novel therapeutic tactic for CXCR4+ HCC cells. T22 was chosen since the https://zanek295tyd9.webdesign96.com/profile